Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 1.30% | $192.23M | $509.42B | 98.71% | 81 Outperform | |
| Roche Holding AG | 1.09% | $160.32M | CHF265.95B | 26.59% | 73 Outperform | |
| Shell (UK) | 1.00% | $147.96M | £180.69B | 24.64% | 73 Outperform | |
| AstraZeneca | 1.00% | $147.80M | $300.78B | 21.96% | 80 Outperform | |
| HSBC Holdings | 0.98% | $144.52M | £214.86B | 46.35% | 80 Outperform | |
| Nestlé SA | 0.95% | $139.67M | CHF202.47B | 0.30% | 71 Outperform | |
| Royal Bank Of Canada | 0.86% | $127.43M | $228.02B | 44.65% | 75 Outperform | |
| Novartis | 0.73% | $107.33M | $306.84B | 40.98% | 80 Outperform | |
| Toyota Motor | 0.68% | $100.56M | ¥44.22T | 19.51% | 80 Outperform | |
| Mitsubishi UFJ Financial Group | 0.63% | $92.89M | ¥29.80T | 26.90% | 76 Outperform |